First Ethicon Physiomesh Hernia Lawsuits Set to Go To Trial in September 2019

Ethicon, Inc., has been under fire with a number of trials brought upon by their Physiomesh Flexible Composite Mesh implants causing health problems in patients which had them implanted for internal hernias and other similar issues.

Seattle, United States - February 23, 2018 /PressCable/ —

Ethicon, Inc., has been under fire with a number of trials brought upon by their Physiomesh Flexible Composite Mesh implants causing health problems in patients which had them implanted for internal hernias and other similar issues.

The current Federal litigation has almost 500 lawsuits against Ethicon in regards to their Physiomesh Flexible Composite Mesh. This product had come onto the market quickly due to the expedited 510(k) process, which allows devices that are similar to products that have already been approved by the FDA to skip their often intense clinical trial approval process.

The product was then used in laparoscopic ventral hernia surgeries from 2010 to May 2016, when it was taken off the market after it was discovered via hernia studies in Europe that the Physiomesh Flexible Composite Mesh was being connected with a higher number of problems than other similar products on the market. These issues included subsequent hernias in the same region of the body and the need for surgeons to go back in to either redo the surgery or adjust the mesh. This resulted in recalls in several countries, not including the United States, which is what has led to this series of lawsuits.

The federal court overseeing the lawsuits that have been brought forth has made a decision regarding how they plan to proceed with the hearings. As of January 19th, 2018, they put forward a Practice and Procedure Order, requiring all parties involved in the lawsuit to put together what is called an Initial Discovery Pool.

In this instance, the Initial Discovery Pool is to be made up of 12 cases, to be chosen from all of the Physiomesh lawsuits filed before the date of January 11th, 2018. As a part of the procedures involved, the Plaintiffs will provide fact sheets by the 15th of June, and the Defendants will provide their sheets by the 31st of July. Additional cases will be added into this pool in late June, with additional due dates being added for both the Plaintiff and Defendant Fact Sheets regarding those cases.

By December 1st, and after the fact sheets have been submitted and reviewed by the appropriate parties, five of the cases in the Initial Discovery Pool will then be brought to court via the trial pool, allowing them to start their cases by the September 2019 date.

Persons who may be affected by the hernia mesh recall and the injuries and illnesses associated with it should take a look at the website https://www.drugwatcher.org/hernia-mesh-lawsuit/. This website provides consumers with all of the latest news and information regarding hernia mesh cases, allowing them to understand their rights and gain access to whatever information that they may need in order to go through with a lawsuit or other legal action related to the case.

Drugwatcher is a company focused on following the medical industry in order to provide the public information about drugs, devices, and medical procedures that may cause unexpected dangers. More information about Drugwatcher goals and purpose can be found at https://www.drugwatcher.org/about-us/. Journalists may utilize this website in order to contact the company regarding media inquiries as well.

Contact Info:
Name: Derek Finch
Email: [email protected]
Organization: Drug Watcher
Address: 1601 5th Ave Suite 705, Seattle, WA 98101, United States

For more information, please visit https://www.drugwatcher.org/

Source: PressCable

Release ID: 302959